FDA Approved: ILUMYA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ILUMYA (tildrakizumab) from Sun Pharmaceutical Industries, Inc., supporting a regulatory update to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Ilumya (tildrakizumab)

Snippet

SUPPL AP for ILUMYA (TILDRAKIZUMAB-ASMN)